Fifth, our study does not provide any information on the effect of OSA treatment on TGF-β1 levels or its effect on melanoma aggressiveness, and therefore no therapeutic recommendations beyond those in place for OSA can be formulated. This evidence concerns the gene TGFB1 and melanoma.